rs145851613

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_145309.6(LRRC51):​c.255C>T​(p.Asp85Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0027 in 1,614,200 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 12 hom. )

Consequence

LRRC51
NM_145309.6 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.956

Publications

0 publications found
Variant links:
Genes affected
LRRC51 (HGNC:55526): (leucine rich repeat containing 51) This gene belongs to the leucine-rich repeat containing family. The encoded protein contains a transmembrane domain and two leucine-rich repeat domains. Unlike in mouse and other mammals, readthrough transcription is observed in primates between this gene and the adjacent transmembrane O-methyltransferase (Tomt) gene. Previously, this locus was annotated as a single gene representing the readthrough transcripts as well as the two different transcript species that encoded different proteins. It has since been split into three genes, including the two stand-alone genes and a third gene representing the readthrough transcription. [provided by RefSeq, Feb 2022]
LRTOMT (HGNC:25033): (leucine rich transmembrane and O-methyltransferase domain containing) This locus represents naturally occurring readthrough transcription between the neighboring LRRC51 (leucine-rich repeat containing 51) and TOMT (transmembrane O-methyltransferase) genes on chromosome 11. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. Multiple reports implicate mutations in this gene in nonsyndromic deafness.[provided by RefSeq, Feb 2021]
LAMTOR1 (HGNC:26068): (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) Enables GTPase binding activity. Contributes to guanyl-nucleotide exchange factor activity and molecular adaptor activity. Involved in several processes, including cholesterol homeostasis; positive regulation of TOR signaling; and regulation of cholesterol transport. Located in lysosome. Part of Ragulator complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 11-72093668-C-T is Benign according to our data. Variant chr11-72093668-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 305986.
BP7
Synonymous conserved (PhyloP=0.956 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 12 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_145309.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRRC51
NM_145309.6
MANE Select
c.255C>Tp.Asp85Asp
synonymous
Exon 4 of 6NP_660352.1Q96E66-1
LRRC51
NM_001318803.2
c.255C>Tp.Asp85Asp
synonymous
Exon 4 of 6NP_001305732.1Q96E66-1
LRRC51
NM_001205138.4
c.201C>Tp.Asp67Asp
synonymous
Exon 3 of 5NP_001192067.1Q96E66-6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRRC51
ENST00000289488.8
TSL:1 MANE Select
c.255C>Tp.Asp85Asp
synonymous
Exon 4 of 6ENSP00000289488.2Q96E66-1
LRRC51
ENST00000541614.5
TSL:1
c.255C>Tp.Asp85Asp
synonymous
Exon 3 of 5ENSP00000438522.1Q96E66-2
LRRC51
ENST00000324866.11
TSL:1
c.255C>Tp.Asp85Asp
synonymous
Exon 4 of 5ENSP00000440693.1Q96E66-3

Frequencies

GnomAD3 genomes
AF:
0.00229
AC:
348
AN:
152190
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00830
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00275
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00311
AC:
783
AN:
251482
AF XY:
0.00326
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00288
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00952
Gnomad NFE exome
AF:
0.00294
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.00275
AC:
4018
AN:
1461892
Hom.:
12
Cov.:
32
AF XY:
0.00278
AC XY:
2023
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.00161
AC:
72
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00199
AC:
52
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00402
AC:
347
AN:
86258
European-Finnish (FIN)
AF:
0.00870
AC:
465
AN:
53420
Middle Eastern (MID)
AF:
0.00295
AC:
17
AN:
5768
European-Non Finnish (NFE)
AF:
0.00260
AC:
2896
AN:
1112010
Other (OTH)
AF:
0.00250
AC:
151
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
243
485
728
970
1213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00228
AC:
348
AN:
152308
Hom.:
0
Cov.:
32
AF XY:
0.00247
AC XY:
184
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41574
American (AMR)
AF:
0.00196
AC:
30
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4822
European-Finnish (FIN)
AF:
0.00830
AC:
88
AN:
10608
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00275
AC:
187
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00241
Hom.:
0
Bravo
AF:
0.00189
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00382
EpiControl
AF:
0.00397

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Autosomal recessive nonsyndromic hearing loss 63 (2)
-
-
2
not provided (2)
-
-
1
LRTOMT-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
9.2
DANN
Benign
0.57
PhyloP100
0.96
Mutation Taster
=297/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145851613; hg19: chr11-71804714; API